The Supply Chain Impacts of GLP-1 Drugs and the Demise of the De Minimis Loophole

Buckle up for this week's Behind The Headlines episode! 🎙️ We're exploring two hot topics shaking up the supply chain:

First up, the demise of De Minimis! The Biden administration's proposal to close this e-commerce loophole could have major repercussions for businesses and consumers alike. Say goodbye to those $11 jeans from Shein?

Next, the GLP-1 revolution! These so-called miracle weight-loss drugs are changing lives, but could they also disrupt the food industry? We're exploring the potential impact on everything from snack sizes to supermarket layouts.

Further reading:

• The Supply Chain Impacts of GLP-1 Drugs and the Demise of the De Minimis Loophole (LIDD)
• De Minimis: Supply Chain Trifles the Law Should be Concerned With (artofprocurement.com)
• What would the demise of de minimis mean for supply chains? | Supply Chain Dive
• Nestlé is releasing a lineup of frozen food for people on Ozempic and other GLP-1 drugs | CNN Business
• Could weight-loss drugs take a bite out of junk food consumption? (economist.com)
• How Supplement Stores, Gyms, etc. Are Trying to Tap Into the Ozempic Boom - The New York Times (nytimes.com)